UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120 | +37.9% | 8,600 | +2.4% | 0.00% | – |
| Q2 2023 | $87 | -91.3% | 8,400 | +4727.6% | 0.00% | – |
| Q2 2022 | $1,000 | -99.2% | 174 | -98.7% | 0.00% | – |
| Q1 2022 | $118,000 | -8.5% | 13,574 | -0.1% | 0.00% | – |
| Q4 2021 | $129,000 | -50.6% | 13,592 | -12.3% | 0.00% | – |
| Q3 2021 | $261,000 | -8.4% | 15,501 | -16.9% | 0.00% | – |
| Q2 2021 | $285,000 | -22.6% | 18,658 | -1.3% | 0.00% | – |
| Q1 2021 | $368,000 | +2.5% | 18,900 | -5.0% | 0.00% | – |
| Q4 2020 | $359,000 | -6.5% | 19,900 | 0.0% | 0.00% | – |
| Q3 2020 | $384,000 | -26.2% | 19,900 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $520,000 | +78.7% | 19,900 | +22.1% | 0.00% | – |
| Q1 2020 | $291,000 | -46.5% | 16,300 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $544,000 | +18.8% | 16,300 | -15.1% | 0.00% | 0.0% |
| Q3 2019 | $458,000 | -33.6% | 19,200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $690,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 900,148 | $23,512,000 | 8.12% |
| Horton Capital Management, LLC | 383,428 | $10,015,000 | 7.55% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $77,177,000 | 1.89% |
| Phoenix Holdings Ltd. | 897,464 | $22,251,000 | 0.94% |
| SHIKIAR ASSET MANAGEMENT INC | 51,175 | $1,337,000 | 0.61% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $19,284,000 | 0.31% |
| Coastal Bridge Advisors, LLC | 37,000 | $966,000 | 0.31% |
| Clal Insurance Enterprises Holdings Ltd | 529,388 | $13,828,000 | 0.27% |
| ALGERT GLOBAL LLC | 10,880 | $284,000 | 0.10% |
| BANK HAPOALIM BM | 14,831 | $387,000 | 0.09% |